Novel indications for autologous fat grafting in reconstruction: scleroderma

Abstract

Scleroderma is a chronic connective tissue disease characterized by inflammation, vascular injury, and progressive skin fibrosis, resulting in significant aesthetic and functional impairments for patients. Current therapies are limited and insufficiently treat the cutaneous manifestations of scleroderma. Autologous fat transfer (AFT) is a surgical technique that has been utilized for many decades for facial rejuvenation. The adipose stem cells (ASCs) present in fat grafts have also shown significant promise for their anti-inflammatory and regenerative properties. Recently, AFT has been repurposed to treat the skin manifestations of systemic sclerosis and localized scleroderma. Studies suggest that AFT in scleroderma patients improves mouth and hand functions, Raynaud’s symptoms, and digital ulcerations. AFT is a safe procedure with rare postoperative complications, making it a promising intervention for the treatment of scleroderma. Further studies are required to better characterize the influence of fat grafts on the recipient site and to establish standards for fat transfer in fibrotic skin diseases.

Keywords

Scleroderma / systemic sclerosis / localized scleroderma / AFT

References

[1] Cutolo M,Smith V.Pathophysiology of systemic sclerosis: current understanding and new insights.Expert Rev Clin Immunol2019;15:753-64.

[2] Marsol I. Update on the classification and treatment of localized scleroderma.Actas Dermosifiliogr2013;104:654-66

[3] van den Hoogen F,Fransen J.2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.Ann Rheum Dis2013;72:1747-55

[4] Czirják L,Müller-Ladner U.Skin involvement in systemic sclerosis.Rheumatology2008;47 Suppl 5:v44-5

[5] Vitiello M,Santana N,Kerdel FA.An update on the treatment of the cutaneous manifestations of systemic sclerosis: the dermatologist's point of view.J Clin Aesthet Dermatol2012;5:33-43 PMCID:PMC3396456

[6] Pearson DR,Pappas-Taffer L.Systemic sclerosis: current concepts of skin and systemic manifestations.Clin Dermatol2018;36:459-74

[7] Strong AL,Brown OH.Fat grafting subjectively improves facial skin elasticity and hand function of scleroderma patients.Plast Reconstr Surg Glob Open2021;9:e3373 PMCID:PMC7861649

[8] Wetterau M,Hazen A.Autologous fat grafting and facial reconstruction.J Craniofac Surg2012;23:315-8

[9] Strong AL,Rubin JP,Levi B.The current state of fat grafting: a review of harvesting, processing, and injection techniques.Plast Reconstr Surg2015;136:897-912 PMCID:PMC4833505

[10] Choi M,Levovitz C,Fadl A.The volumetric analysis of fat graft survival in breast reconstruction.Plast Reconstr Surg2013;131:185-91.

[11] Clauser LC,Galiè M.Structural fat grafting: facial volumetric restoration in complex reconstructive surgery.J Craniofac Surg2011;22:1695-701.

[12] Coleman SR.Structural fat grafting: more than a permanent filler.Plast Reconstr Surg2006;118:108S-20S

[13] Coleman SR.Structural fat grafts: the ideal filler?.Clin Plast Surg2001;28:111-9.

[14] Gir P,Oni G,Mojallal A.Fat grafting: evidence-based review on autologous fat harvesting, processing, reinjection, and storage.Plast Reconstr Surg2012;130:249-58

[15] Kaufman MR,Huang C.Autologous fat transfer for facial recontouring: is there science behind the art?.Plast Reconstr Surg2007;119:2287-96.

[16] Han S,Hwang KC.Adipose-derived stromal vascular fraction cells: update on clinical utility and efficacy.Crit Rev Eukaryot Gene Expr2015;25:145-52

[17] Thomson JA,Shapiro SS.Embryonic stem cell lines derived from human blastocysts.Science1998;282:1145-7

[18] Rosendahl AH,Krieg T.Pathophysiology of systemic sclerosis (scleroderma).Kaohsiung J Med Sci2022;38:187-95

[19] Strong AL,Kozlow JH.Fat grafting for the treatment of scleroderma.Plast Reconstr Surg2019;144:1498-507

[20] Roumm AD,Medsger Jr TA.Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations.Arthritis Rheum1984;27:645-53

[21] Fleischmajer R.Skin capillary changes in early systemic scleroderma: electron microscopy and "in vitro" autoradiography with tritiated thymidine.Arch Dermatol1976;112:1553-7

[22] Kahaleh B.Vascular disease in scleroderma: mechanisms of vascular injury.Rheum Dis Clin North Am2008;34:57-71; vi

[23] Diot E,Guilmot JL.Systemic sclerosis and occupational risk factors: a case-control study.Occup Environ Med2002;59:545-9 PMCID:PMC1740346

[24] Khalil N,Sporn M.Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation.J Exp Med1989;170:727-37 PMCID:PMC2189427

[25] Gilbane AJ,Holmes AM.Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells.Arthritis Res Ther2013;15:215 PMCID:PMC4060542

[26] Jelaska A.Role of apoptosis and transforming growth factor β1 in fibroblast selection and activation in systemic sclerosis.2000;43:2230-9.

[27] Hinz B,Thannickal VJ,Bochaton-Piallat ML.The myofibroblast: one function, multiple origins.Am J Pathol2007;170:1807-16. PMCID:PMC1899462

[28] Hinz B.Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases.Nat Rev Rheumatol2020;16:11-31 PMCID:PMC7913072

[29] Santiago B,Rivero M.Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts.2001;44:1667-76

[30] Stummvoll GH.Current treatment options in systemic Sclerosis (Scleroderma).Acta Med Austriaca2002;29:14-9

[31] Ceccarelli S,Anastasiadou E,Marchese C.Immunomodulatory effect of adipose-derived stem cells: the cutting edge of clinical application.Front Cell Dev Biol2020;8:236 PMCID:PMC7180192

[32] Melief SM,Fibbe WE.Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts.Stem Cells Transl Med2013;2:455-63 PMCID:PMC3673757

[33] Montespan F,Sensébé L,Rouas-Freiss N.Osteodifferentiated mesenchymal stem cells from bone marrow and adipose tissue express HLA-G and display immunomodulatory properties in HLA-mismatched settings: implications in bone repair therapy.J Immunol Res2014;2014:230346 PMCID:PMC4022112

[34] Soleymaninejadian E,Samadian E.Immunomodulatory properties of mesenchymal stem cells: cytokines and factors.Am J Reprod Immunol2012;67:1-8.

[35] Strioga M,Darinskas A,Michalek J.Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells.Stem Cells Dev2012;21:2724-52

[36] Min CK,Park G,Oh IH.IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation.Bone Marrow Transplant2007;39:637-45

[37] Amos PJ,Stapor PC.Human adipose-derived stromal cells accelerate diabetic wound healing: impact of cell formulation and delivery.Tissue Eng Part A2010;16:1595-606 PMCID:PMC2952117

[38] Gnecchi M,Liang OD.Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.Nat Med2005;11:367-8.

[39] Merfeld-Clauss S,March KL.Adipose tissue progenitor cells directly interact with endothelial cells to induce vascular network formation.Tissue Eng Part A2010;16:2953-66 PMCID:PMC2928048

[40] Wang L,Zhou X.Author Correction: exosomes secreted by human adipose mesenchymal stem cells promote scarless cutaneous repair by regulating extracellular matrix remodelling.Sci Rep2021;11:3245 PMCID:PMC7851382

[41] Marten TJ.Fat grafting in facial rejuvenation.Clin Plast Surg2015;42:219-52

[42] Coleman SR.Structural fat grafting.Aesthet Surg J1998;18:386-8.

[43] Blezien O,Nicoletti GF.Effects of fat grafting containing stem cells in microstomia and microcheilia derived from systemic sclerosis.Aesthetic Plast Surg2017;41:839-44

[44] Ferreli C,Parodi A,Rongioletti F.Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review.Clin Rev Allergy Immunol2017;53:306-36

[45] Jaeger VK,Allanore Y.EUSTAR co-authorsIncidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study.PLoS One2016;11:e0163894 PMCID:PMC5051961

[46] Bajraktari IH,Sherifi F,Lahu A.Oral manifestations of systemic sclerosis and correlation with anti-topoisomerase I antibodies (SCL-70).Med Arch2015;69:153-6 PMCID:PMC4500385

[47] Maddali Bongi S,Galluccio F.Efficacy of a tailored rehabilitation program for systemic sclerosis.Clin Exp Rheumatol2009;27(3 Suppl 54):44-50

[48] Gheisari M,Nobari N,Mozafari N.Autologous fat grafting in the treatment of facial scleroderma.Dermatol Res Pract2018;2018:6568016. PMCID:PMC6093005

[49] Del Papa N,Sambataro D.Autologous fat grafting in the treatment of fibrotic perioral changes in patients with systemic sclerosis.Cell Transplant2015;24:63-72

[50] Yang Z,He Y,Han X.Comparison of microfat, nanofat, and extracellular matrix/stromal vascular fraction gel for skin rejuvenation: basic research and clinical applications.Aesthet Surg J2021;41:NP1557-70

[51] Nguyen PS,Gay AM,Magalon G.Development of micro-injection as an innovative autologous fat graft technique: the use of adipose tissue as dermal filler.J Plast Reconstr Aesthet Surg2012;65:1692-9

[52] Sautereau N,Truillet R.Efficacy of autologous microfat graft on facial handicap in systemic sclerosis patients.Plast Reconstr Surg Glob Open2016;4:e660 PMCID:PMC4874304

[53] Alharbi Z,Almakadi S,Vogt M.Conventional vs. micro-fat harvesting: how fat harvesting technique affects tissue-engineering approaches using adipose tissue-derived stem/stromal cells.J Plast Reconstr Aesthet Surg2013;66:1271-8

[54] Magalon G,Sautereau N,Sabatier F.Regenerative approach to scleroderma with fat grafting.Clin Plast Surg2015;42:353-64, viii-ix

[55] Virzì F,Giammona A.Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients.Stem Cell Res Ther2017;8:236 PMCID:PMC5651639

[56] Willemsen JC,Vermeulen KM.The effects of platelet-rich plasma on recovery time and aesthetic outcome in facial rejuvenation: preliminary retrospective observations.Aesthetic Plast Surg2014;38:1057-63

[57] Maeda M,Hirano H,Ichiki Y.Pitting scars in progressive systemic sclerosis.Dermatology1993;187:104-8

[58] Bene MD,Rovati L,Erba G.Autologous fat grafting for scleroderma-induced digital ulcers. An effective technique in patients with systemic sclerosis.Handchir Mikrochir Plast Chir2014;46:242-7

[59] McMahan ZH.Raynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and management.Int J Clin Rheumtol2010;5:355-70 PMCID:PMC4624318

[60] Hachulla E,Launay D.Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study.J Rheumatol2007;34:2423-30

[61] Granel B,Jouve E.Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial.Ann Rheum Dis2015;74:2175-82 PMCID:PMC4680117

[62] Giuggioli D,Cocchiara E.Autologous fat grafting in the treatment of a scleroderma stump-skin ulcer: a case report.Case Reports Plast Surg Hand Surg2021;8:18-22 PMCID:PMC7889081

[63] Del Papa N,Sambataro D.Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis.Cell Transplant2015;24:2297-305.

[64] Bank J,Henry GI.Fat grafting to the hand in patients with Raynaud phenomenon: a novel therapeutic modality.Plast Reconstr Surg2014;133:1109-18

[65] Tonnard P,Peeters G,Cornelissen M.Nanofat grafting: basic research and clinical applications.Plast Reconstr Surg2013;132:1017-26.

[66] Scuderi N,Onesti MG.Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis.Cell Transplant2013;22:779-95

[67] Careta MF.Localized scleroderma: clinical spectrum and therapeutic update.An Bras Dermatol2015;90:62-73 PMCID:PMC4323700

[68] Takeda A,Hayashi K,Nemoto M.Surgical management of breast deformity in a young patient with localized scleroderma: a case report and literature review.Aesthet Surg J2013;33:691-7.

[69] Kim KT,Chung EH.A surgical approach to linear scleroderma using medpor and dermal fat graft.Arch Craniofac Surg2019;20:112-5 PMCID:PMC6505431

[70] Chicco M,Lin FY,Lee MM.Combination of autologous fat grafting and negative-pressure wound therapy for the treatment of scalp linear scleroderma.J Craniofac Surg2022;33:e459-61

[71] Ayoub R.Treatment of linear scleroderma "En coup de Sabre" with single-stage autologous fat grafting: a case report and review of the literature.J Cosmet Dermatol2021;20:285-9

[72] Pinski KS.Autologous fat transplantation. Long-term follow-up.J Dermatol Surg Oncol1992;18:179-84

[73] Palmero ML,Laxer RM,Pope E.En coup de sabre scleroderma and Parry-Romberg syndrome in adolescents: surgical options and patient-related outcomes.J Rheumatol2010;37:2174-9

[74] Agrawal K,Choudhary S,Gupta S.A new minimally invasive aesthetic procedure for correction of frontal coup de sabre deformity in romberg's syndrome.J Maxillofac Oral Surg2015;14:401-6 PMCID:PMC4379301